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ABSTRACT  
The global epidemic of hepatitis B is a significant public health problem. The endemicity of HBV infection 
used to be believed high in Yemen. Data for the prevalence of HBsAg among children in rural and urban areas 
in Yemen is scarce and incompetent. The study was made to determine prevalence of HB surface antigen 
among children in 2 selected areas in Yemen. Eight hundred forty and 212 children were randomly chosen from 
Sana'a city and Shabowah governorate, respectively. Sera were tested for HBs antigen by ELISA technique, and 
HB genome was tested for positive HB surface antigen specimens to confirm positivity using polymerase chain 
reaction (PCR) -based test. Each's data collected in a pre-designed questionnaire including sex, age, and risk 
factors of HBV and prior vaccine of HBV.  
The prevalence of HB surface antigen among children in Sana'a city was only 1.8%, and in Shabowah 
governorate was 3.8%. There was a significant association of non-vaccinated children, birth by cesarean, and 
with a history of parental exposure with contracting HBV infection.  Evidence from these studies in Yemen 
suggests that there is a steady increase in exposure to HBV over a lifetime. Hospital-acquired HBV infection is 
common in Yemen, and high vaccination coverage rate should be achieved, particularly in rural areas, in 
parallel with health education.  
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INTRODUCTION  
Hepatitis B virus (HBV) infection is a significant global health problem, with 2 billion people infected 
worldwide, and 350 million suffering from chronic HBV infection. The 10th leading cause of death worldwide, 
HBV infections result in 500 000 to 1.2 million deaths per year caused by chronic hepatitis, cirrhosis, and 
hepatocellular carcinoma; the last accounts for 320 000 deaths per year
1, 2, 3
. In developed countries, the disease 
is relatively rare and gained primarily in adulthood in which injection drug abuse and unprotected sex are the 
main methods, where in Asia and the majority of Africa including Yemen, chronic HBV infection is widespread 
and typically acquired perinatally or in infancy 
4-8
. The endemicity of HBV was estimated high in Yemen, 
anywhere the prevalence of positive HBsAg among adult's ranges from 8 % to 20 %, among infants, was 4.1%, 
and up to 50 % of the populations commonly have serological evidence of previous HBV infection in old 
reports
9-15
. On the other hand, recent studies reported a lower rate of HBsAg in which it ranges from 0.7-2% 
among general population as well as children 
16, 17, 18
. More efficacious treatments, mass immunization 
programs, and safe injection techniques are essential for eliminating HBV infection and reducing global HBV-
related morbidity and mortality 
19
. Reliable and efficient vaccines for HBV infection have been obtainable since 
1982. The applications of mass immunization programs, which have been suggested by the WHO since 1991, 
have considerably decreased the incidence of HBV infection among infants, children, and adolescents in many 
countries 
1, 2
. However, not all countries have adopted these recommendations,  and there remains a large 
number of persons that were infected with HBV which including Yemen in which the coverage rate of HBV 
vaccine in urban was only 69.9%, 
3, 17
. The main aim of this study is to determine the prevalence of HB surface 
antigen among a sample of children in 2 selected areas in Yemen and analysis potential risk factors of HBV 
transmission among the chosen children.  
SUBJECTS AND METHODS  
Study area  
Misspelled word This cross-sectional sero-epidemiological study was conducted in healthy children less than 11 
years of age in Sana'a city and in healthy children less than 16 years of age in Shabwah governorate Yemen. 
 Yemen is situated on Southwest Asia in the Arabian Peninsula. It is bounded by the Red Sea to the west, 
Sultanate of Oman to the east, Saudi Arabia to the north and the Arabian Sea to the south.  In 2008 the 
population was estimated at 21,843,554, living in 3,058,299 households. The structure of the population is 
characteristic of a developing country, by the rural population counting  71% of the total. The majority of the 
inhabitants are young, with 45% below age 15 years, while the over 64 years age group represents only 3.4%. 
The literacy rate is 47% among those 15 years and older (males 63%, females 31%), the average household size 
7.1 persons, the fertility rate 6.2, the annual growth rate of population 2.9% and the poverty rate about 47%.  
Life expectancy at birth female/male is 67/63 years, and the probability of dying under five years in 2019 was 
320/1000 live births. These and other factors as Saudi /Emirates aggression contribute to Yemen's low ranking 
in the Development Index cited in the World Human Development Report - 178 among the 189 countries that 
were rated in the year 2018
20
.  
Yemen introduced universal immunization against HBV for infants and high-risk groups in early 2000, but 
feed-back on the coverage rate of vaccination and its efficacy in the community have been ignored for a long 
period. Also, there has been inadequate information on the prevalence and risk determinants of viral hepatitis as 
well as on vaccination coverage rate among children in Yemen. UNICEF provided the vaccines from different 
reliable sources. 
Study populations and Sample size  
This cross sectional study was carried out during 3 months, starting in January 2016 and ending in March 2016, 
after the approval of the Department of Medical Microbiology, in the Faculty of Medicine and Health Sciences, 
Sana'a University to the study proposal. A consent form was filled by the parents for each participant. The 
sample sizes for or study was calculated as follow: First we considered the rate of HBV in Sana'a city, 
difference (worst acceptable result higher or lower the true rate) and confidence interval as 2%, 0.5% and 95% 
respectively. According to our calculations, a sample size of at least 752 subjects was required from the 
population of children under 11 years in Sana'a city (639358 children) 
20
 which the sample will be selected; this 
was selected by systematic random method. All health centers and primary schools in Sana'a were listed (27 
centers, 33 schools), then by simple random selection 4 of these centers and 4 of these schools were selected; 
finally, every 5th child admitted to these health centers for normal check and vaccination was selected (about 
17% of male children and 13% of female children who refused to donate blood were excluded), and, every 5th 
child in the selected classes was selected (about 7% of male children and 6% of female children who refused to 
donate blood were excluded). Second, we considered the rate of HBV in Shabwah governorate, the difference 
(worst acceptable result higher or lower the true rate) and confidence interval as 3%, 0.5% and 95% 
respectively. According to our calculations, a sample size of at least 178 subjects was required from the 
population of children under 16 years in Shabwah governorate (255600 children) 
20
 which the sample will be 
selected; this was selected by systematic random method. All health centers and primary schools in Atag, 
Bayhan and Mayfa'a in Shabwah governorate were selected (3 centers, 4 schools), then every 5th child admitted 
to these health centers for normal check and vaccination was selected (about 36% of male children and 39% of 
female children who refused to donate blood were excluded), and, every 5th child in the selected classes was 
selected (about 14% of male children and 9% of female children who refused to donate blood were excluded).  
Data collection  
A full history was taken from each studied individual or from parents; and the findings were recorded in a 
predesigned questionnaire. The data collected included name, age at the time of the study, sex, residence, status 
and risk factors of HBV contracting; and laboratory results.  
Laboratory tests  
Capillary blood or vein puncture of whole blood was collected; then sera were separated and tested for HB 
surface antigen by an Enzyme-linked Immunosorbant assay (ELISA) using a commercially available kit 
provided by Biokit, Spain. Specimens which proved repeatedly reactive by EIA in two separate tests were 
 considered positive for hepatitis B surface antigen. In addition HB genome was tested for positive HB surface 
antigen specimens to confirm positivity using a commercial polymerase chain reaction (PCR) -based test 
(Taqman amplicor, Roche, USA) and all were positive.  
Statistical analysis  
Personal and clinical data were obtained from each subject and recorded into a pre- designed questionnaire, 
then the data were statistically analyzed by a software version for statistical significance (Epi Info version 6, 
CDC, Atlanta, USA). From two-by-two tables, the odds ratios were calculated and P-value was determined 
using the uncorrected chi square test. Fisher’s exact test was used for the small expected cell sizes with a two-
tailed probability value.  
RESULTS  
 Tables 1 and 2 outline prevalence and the odds ratio (OR) estimates by their 95% confidence intervals (95% 
CI), and by Fisher’s exact test for cell value less than 5, for positive serological tests of hepatitis B virus and 
expected risk factors of contracting Hepatitis B virus, and with statistically significant P-value using 
uncorrected chi-square test.  The crude seroprevalence among children in Sana'a city was 1.8% and it was 3.8% 
for children from Shabowah governorate. When the age of children was considered, the highest rate of HBV 
among children in Sana'a city was in age group 9-10 years (2.3%), with associated OR equal to 2.7, CI=0.3 - 25, 
but this result was not statistic significance (p=0.3). The lowest rate of HBV among children in Sana'a city was 
in age group 1-2 years (0.85%) (table 1).  
The highest rate of HBV among children in Shabwah governorate was in age group 11-15 years (5.1%), with 
associated OR equal to 2.4, CI=0.29-21, but this result was not statistic significance (p=0.39). The rates of 
HBV in Shabwah in age groups 1-5 years and 6-10 years were similar (2.1%). In conclusion there was non-
significant effect of older age on contracting hepatitis B virus in both selected area children (Table 1, 2).  
In the case of risk factors of hepatitis B virus infection for children in Sana'a city, there was a significant 
association of non vaccination to HBV vaccine (OR=4.2, CI=1.23-15.9, p=0.007), and with history of parental 
exposure (OR=4.05, CI=1.1-14.3, p=0.01). Also there was not significant association of birth by cesarean in 
which OR=3.3, CI=0.0-16, p=0.1) and birth in hospital (OR=1.27, CI=0.41-3.9, p=0.64) (Table 1). In the case 
of risk factors of hepatitis B virus infection for children in Shabwah governorate, it was found that there was a 
highly significant association of contracting HBV infection with non vaccination to HBV vaccine with 
significant rate equal to 5.5% (OR and CI =undefined, p=0.045), birth in hospital(OR=5.8, CI=1.01- 31.4, 
p=0.01) and birth by cesarean (OR=5.6, CI=0.7-38.7, p=0.02), but not significant with history of parental 
exposure (OR=2.24, CI=0.5 -11, p=0.25) (Table 2).  
DISCUSSION  
The prevalence rate of HB surface antigen in our study was variants among selected healthy children in the two 
selected areas these differences in the prevalence rates might be the geographical differences and the national 
immunization programmes vaccination coverage in the capital city of Sana'a (high) and urban area of Shabowah 
(low) and or related to the differences in the classification of age groups. The prevalence rate in our study in 
Sana'a city was 1.8%, is lower than that reported among infants in Sana'a city previously where the rate was 
4.1% but the rate in Shabwah (3.8%) is roughly similar to that reported previously in Sana'a city among infants 
10
. Although it is difficult to compare the prevalence rates reported in our study (among children), with that 
reported by Al-Shamahy et al. 
10, 11
 (among children and mothers and among blood donors etc), it seems that the 
rate of HBsAg has decreased dramatically. Introducing hepatitis B vaccine within the national immunization 
programmes improvement of the people’s knowledge about hepatitis risk factors through educational 
programmes, and the availability of measures to diagnose hepatitis in health centers and blood banks might 
explain this decrease 
16,18, 21
.  
The rates of HBV in our study was higher than that reported in Northern, Western, and central Europe, North 
America, and Australia, children and general population where the rates of HBV surface antigen was ranged 
 from 0.2-0.5%, 
22
. In other hand the crude rate of HBV surface antigen in our study was similar to that reported 
in Eastern Europe, the Mediterranean, Russia and the Russian Federation, Southwest Asia, Central and South 
America among children general population where the rates of HBV surface antigen was ranged from 2 -7 %, 
23
, 
but lower than that reported in Parts of China, Southeast Asia, and tropical Africa among general population 
where the rates of HBV surface antigen was ranged from 8-20%,
22
. These differences in the prevalence rates 
might be explained by the geographical differences in the availability of services and vaccination programmers.  
Many other studies in nearby countries have shown a lower prevalence of hepatitis B among children, as Saudi 
Arabia (0.05%) 
24
, This may be because the good availability of services and vaccination programmers in Saudi 
Arabia and there is insufficient protection for patient children admitted to hospitals in Yemen, since 
sterilization, disinfection and general standards of training and proficiency are generally lacking in most 
hospitals in Yemen.  
HBV infection effects all ages everywhere
22-26
. There was slightly trend toward increased levels of HB surface 
antigen with the older children where prevalence rate is ranged from 0.84% in 1-2 years group to 2.3% in 6-8 
years group in Sana'a city and this trend toward increased levels of HB surface antigen with the older children is 
more clear in Shabowah governorate where the rate is ranged from 2.1% in 1-5 years old to 5.1% in 11-15 years 
group (tables 1, 2). The increasing of prevalence rate with increasing age in our study could indicate an 
accumulation risk of infection over time. In addition, the results indicated that horizontal spread of HBV may 
be of greater importance than vertical transmission.  
The study illustrates that children in Yemen mainly in rural areas as Shabowah governorate are at a high risk of 
becoming infected in their early years. The first risk for infection occurs in the first few days spent in hospitals 
during normal delivery (OR=5.84, p=0.01) or by cesarean section (OR=5.6, p=0.02), and this confirms that use 
of unsterilized or inadequately sterilized contaminated instruments are a possible route of infection. It is 
possible that there was insufficient protection for children admitted to hospitals in Yemen. Sterilization, 
disinfection and general standards of training and proficiency are generally deficient in most hospitals in Yemen 
particularly in rural areas.  
The rate of HBV infection was higher in Shabowah area (3.8%) than in Sana'a city this regional variation might 
be due to non-uniformities in immunization and engagement in risky behaviors across different sites. Also our 
study shows the important of HBV vaccine in prevent infections (table 1,2) in which higher risk of contracting 
HBV infection among non-vaccinated children and more HBs Ag-positive cases were from unvaccinated 
children and rural area suggesting of poorer vaccination coverage of the rural population.  
Evidence from these studies in Yemen suggests that there is a steady increase in exposure to HBV over a 
lifetime. Hospital-acquired HBV infection is very common in Yemen, and prevention is eventually possible by 
applying standard policies of sterilization, disinfection and personal training to implement this policy and 
guarantee refinements in the screening of blood donors. In Yemen, vaccination should be considered for all 
children and programs to immunize all newborn Babies with a goal of 80% coverage or more should be 
performed in the next 2 to 4 years particularly in rural areas, in the same with health education. 
CONCLUSION 
   There was a significant association of non-vaccinated children, birth by cesarean, and with history of parental 
exposure with contracting HBV infection.  Evidence from these studies in Yemen suggests that there is a steady 
increase in exposure to HBV over a lifetime. Hospital-acquired HBV infection is very common in Yemen, and 
high vaccination coverage rate should be achieved particularly in rural areas, in parallel with health education. 
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 Table 1: Prevalence of HB surface antigen in different age groups and risk factor analysis of HBV in a sample 
of children under 10 years old, in Sana'a city, Yemen Factors 
Age groups HB S Ag positive OR CI P value 
No % 
1-2 years (n=119)  
Reference  
1  0.85   
3-5 years ( n=274)  5  1.8  2.1 0.25-18.9  0.46  
6-8 years ( n=273)  5  1.8  2.2 0.25-19  0.46  
9-10 years ( n=174)  4  2.3  2.7  0.3- 25  0.3 
Total ( n=840) 15 1.8  
Factors  
Vaccinated to HBV  
Yes  (n=504) Reference 
 
4  
 
0.79  
 
No   (n=336)  11  3.3  4.2  1.23-15.9  0.007  
Birth in hospital 
(n=334)  
7  2  1.27  0.41-3.9  0.64  
No (n= 506 )  
Reference 
8 1.6  
Birth by cesarean  Yes 
(n=39)  
 
2  
 
5.1  
 
3.3  
 
0-16  
 
0.1  
No (n= 801 )  
Reference 
13 1.6  
Parental exposure Yes 
  (n=72)  
 
4  
 
5.6  
 
4.05  
 
1.1-14.3  
 
0.01  
N0 (n=  768 ) 
 Reference 
11 1.4  
 
 
 Table 2: Prevalence of HB surface antigen in different age groups and risk factor analysis of HBV in a sample 
of children under 15 years old, in Shabowah governorate, Yemen Factors 
Age groups HB S Ag positive OR CI P value 
No % 
1-5 years  (n=47)  
Reference 
1  2.1   
6-10 years ( n=48)  1  2.1  0.97  0.05-16.1  0.98  
11-15 years ( n=117)  6  5.1  2.4  0.29- 21  0.39  
Total  (n=212) 8 3.8    
Factors  
Vaccinated to HBV Yes 
( n=69) Reference 
 
0  
 
0  
 
No  ( n=143)  8  5.5  undefined  0.045  
Birth in hospital  
Yes  (n=22)  
 
3  
 
13.6  
 
5.8  
 
1.01-31.4  
 
0.01  
No  (n=190) 
Reference 
5 2.6  
Birth by cesarean  
Yes ( n=13) 
 
2  
 
15.4  
 
5.6  
 
0.7-38.7  
 
0.02  
No  (n= 199 ) 
Reference 
6 3  
Parental exposure  
 
Yes  (n=67) 
 
 
4  
 
 
6  
 
 
2.24  
 
 
0.5-11  
 
 
0.25  
No  (n= 145  ) 
Reference 
4 2.8  
 
